Related Experiment Video
Updated: Nov 11, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Artificial intelligence: Deep learning in oncological radiomics and challenges of interpretability and data
Panagiotis Papadimitroulas1, Lennart Brocki2, Neo Christopher Chung3
1Bioemission Technology Solutions - BIOEMTECH, Athens, Greece; 3DMI Research Group, Department of Medical Physics, University of Patras, Rion GR 265 04, Greece.
This article reviews how advanced computer models analyze medical images to improve cancer diagnosis and treatment, while highlighting the need for better data sharing and clearer explanations of how these models make decisions.
Area of Science:
- Computational oncology within Deep Learning research
- Diagnostic imaging and medical informatics
Background:
No prior work had resolved the full integration of advanced computational models within modern cancer care. That uncertainty drove researchers to investigate how automated systems extract hidden patterns from medical scans. Prior research has shown that machine learning algorithms significantly enhance diagnostic accuracy in various clinical settings. However, current systems often struggle with limited data availability and restricted generalizability across different hospital environments. This gap motivated a critical look at how these tools perform when applied to diverse patient populations. It was already known that deep neural networks offer superior performance in complex image processing tasks compared to traditional methods. Yet, the lack of standardized data harmonization remains a persistent barrier to widespread clinical adoption. These challenges highlight the urgent need for robust frameworks that ensure model reliability and transparency in oncology.
Purpose Of The Study:
The aim of this study is to review the foundational principles of radiomics and deep learning within the context of cancer care. Researchers seek to address the persistent challenges of model interpretability and data standardization. This work explores how computational methods can be better integrated into clinical workflows to improve diagnostic precision. The authors examine the potential of explainable artificial intelligence to clarify automated decision-making processes. This study addresses the problem of limited dataset size that currently hampers the generalizability of many models. The motivation is to provide a comprehensive overview of how hidden biomarkers can be extracted from medical images. The review investigates the requirements for multicenter data collection to enhance the robustness of diagnostic tools. This effort aims to establish a clearer path toward the practical application of advanced computational systems in oncology.
Main Methods:
Review approach involved synthesizing current literature on radiomics feature extraction techniques. The authors examined how deep neural networks process anatomical and functional medical images. This study evaluated existing methodologies for identifying hidden biomarkers within large-scale imaging datasets. The investigation focused on the intersection of machine learning and clinical diagnostic requirements. Researchers assessed various interpretability frameworks designed to enhance model transparency. The analysis scrutinized the limitations of current studies regarding dataset size and generalizability. This approach prioritized identifying strategies for effective data harmonization across multiple clinical sites. The review synthesized evidence to outline the requirements for developing robust, explainable computational models.
Main Results:
Key findings from the literature indicate that deep neural networks demonstrate outstanding performance in complex image processing tasks. The review highlights that current models frequently suffer from restricted applicability due to limited training datasets. Evidence suggests that explainable artificial intelligence methods are becoming vital for clinical classification and prediction. The literature shows that radiomics can uncover hidden quantitative features from standard medical scans. Findings reveal that multicenter data recruitment is essential to increase the variability of identified biomarkers. The synthesis shows that most existing studies lack the necessary scale for broad clinical implementation. Results indicate that interpretability tools help bridge the gap between algorithmic outputs and physician understanding. The literature confirms that robust model development requires standardized data harmonization to ensure consistent diagnostic accuracy.
Conclusions:
The authors propose that large-scale multicenter data collection is necessary to validate radiomic biomarkers. Synthesis and implications suggest that explainable models will improve clinical trust and decision-making accuracy. Researchers emphasize that overcoming data fragmentation is a prerequisite for robust diagnostic performance. The review indicates that deep learning architectures require standardized inputs to achieve generalized applicability. Authors argue that transparency in algorithmic processing helps clinicians understand automated predictions. The study highlights that future progress depends on bridging the gap between computational potential and clinical practice. Evidence points toward the necessity of integrating interpretability tools into standard diagnostic workflows. The review concludes that collaborative efforts are required to refine these advanced computational systems for patient care.
Frequently Asked Questions
The researchers propose that deep neural networks extract hidden biomarkers from medical images to improve diagnostic precision. Unlike traditional methods, these systems identify complex quantitative features that are not visible to the human eye, thereby enhancing the personalization of therapeutic strategies in radiation oncology.
Explainable artificial intelligence, or XAI, serves as a tool to demystify how models reach specific conclusions. While standard deep learning often functions as a black box, XAI methods provide transparency, allowing clinicians to interpret the logic behind automated classifications and predictions.
The authors state that multicenter recruitment is necessary to increase biomarker variability. This approach ensures that models are trained on diverse datasets, which prevents overfitting and improves the generalization of findings compared to studies relying on single-center, limited data sources.
Large datasets act as the foundation for training robust algorithms. By incorporating diverse imaging data, researchers can better account for biological variability, which is a significant improvement over models trained on smaller, homogeneous sets that often fail in real-world clinical applications.
The study measures performance through the extraction of quantitative features from anatomical and functional images. This process differs from qualitative assessment, as it provides objective, numerical data that can be statistically analyzed to predict clinical outcomes more accurately than subjective human interpretation.
The researchers propose that the future of oncology relies on balancing computational power with interpretability. They argue that unless models become transparent and data harmonization is achieved, the clinical value of radiomics will remain limited compared to its theoretical potential.

